1t7i
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1t7i.gif|left|200px]] | [[Image:1t7i.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1t7i", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | | | + | --> |
| - | | | + | {{STRUCTURE_1t7i| PDB=1t7i | SCENE= }} |
| - | + | ||
| - | + | ||
| - | }} | + | |
'''The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor.''' | '''The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor.''' | ||
| Line 32: | Line 29: | ||
[[Category: Schiffer, C A.]] | [[Category: Schiffer, C A.]] | ||
[[Category: Wigerinck, P B.T P.]] | [[Category: Wigerinck, P B.T P.]] | ||
| - | [[Category: | + | [[Category: Drug resitance]] |
| - | [[Category: | + | [[Category: Hiv-1 protease]] |
| - | [[Category: | + | [[Category: Substrate envelope]] |
| - | [[Category: | + | [[Category: Thermodynamic]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 09:37:50 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 06:37, 3 May 2008
The structural and thermodynamic basis for the binding of TMC114, a next-generation HIV-1 protease inhibitor.
Overview
The screening of known HIV-1 protease inhibitors against a panel of multi-drug-resistant viruses revealed the potent activity of TMC126 on drug-resistant mutants. In comparison to amprenavir, the improved affinity of TMC126 is largely the result of one extra hydrogen bond to the backbone of the protein in the P2 pocket. Modification of the substitution pattern on the phenylsulfonamide P2' substituent of TMC126 created an interesting SAR, with the close analogue TMC114 being found to have a similar antiviral activity against the mutant and the wild-type viruses. X-ray and thermodynamic studies on both wild-type and mutant enzymes showed an extremely high enthalpy driven affinity of TMC114 for HIV-1 protease. In vitro selection of mutants resistant to TMC114 starting from wild-type virus proved to be extremely difficult; this was not the case for other close analogues. Therefore, the extra H-bond to the backbone in the P2 pocket cannot be the only explanation for the interesting antiviral profile of TMC114. Absorption studies in animals indicated that TMC114 has pharmacokinetic properties comparable to currently approved HIV-1 protease inhibitors.
About this Structure
1T7I is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor., Surleraux DL, Tahri A, Verschueren WG, Pille GM, de Kock HA, Jonckers TH, Peeters A, De Meyer S, Azijn H, Pauwels R, de Bethune MP, King NM, Prabu-Jeyabalan M, Schiffer CA, Wigerinck PB, J Med Chem. 2005 Mar 24;48(6):1813-22. PMID:15771427 Page seeded by OCA on Sat May 3 09:37:50 2008
